Hillery, C A; Du, M C; Wang, W C et al. (2000) Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin. Br J Haematol 109:322-7
|
Hillery, C A; Scott, J P; Du, M C (1999) The carboxy-terminal cell-binding domain of thrombospondin is essential for sickle red blood cell adhesion. Blood 94:302-9
|
Hillery, C A (1998) Potential therapeutic approaches for the treatment of vaso-occlusion in sickle cell disease. Curr Opin Hematol 5:151-5
|
Hillery, C A; Mancuso, D J; Evan Sadler, J et al. (1998) Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets. Blood 91:1572-81
|
French 2nd, J A; Kenny, D; Scott, J P et al. (1997) Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. Blood 89:4591-9
|
Hillery, C A; Du, M C; Montgomery, R R et al. (1996) Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood 87:4879-86
|